偏头痛的欧洲治疗指南述评。
A review of current European treatment guidelines for migraine.
机构信息
University Centre for Adaptive Disorders and Headache (UCADH), Pavia, Italy.
出版信息
J Headache Pain. 2010 Feb;11(1):13-9. doi: 10.1007/s10194-009-0179-2. Epub 2009 Dec 18.
Abstract
Migraine is one of the ten most disabling disorders worldwide, and despite recent developments in the management of migraine, it remains underdiagnosed and undertreated. Guidelines for the management of migraine aim to improve the quality of patient care and to assist professionals in decision making in relation to the overall healthcare process. Most European countries have published national clinical practice guidelines for migraine treatment. These guidelines need to be kept up-to-date with the most recent best clinical evidence and therapeutic strategies to ensure their optimal use to improve health outcomes. The aim of this review is to compare the English language guidelines available across Europe, analyzing differences and similarities, in order to provide a general overview to assist in assessing whether a European consensus on migraine treatment can be achieved.
摘要
偏头痛是全球十大致残性疾病之一，尽管近年来偏头痛的管理取得了一些进展，但它仍然存在诊断不足和治疗不足的情况。偏头痛管理指南旨在提高患者护理质量，并帮助专业人员在整体医疗保健过程中做出决策。大多数欧洲国家都发布了偏头痛治疗的国家临床实践指南。为了确保最佳使用这些指南来改善健康结果，需要根据最新的最佳临床证据和治疗策略对其进行更新。本综述的目的是比较欧洲现有的英语语言指南，分析其差异和相似之处，以便提供一个总体概述，帮助评估是否可以就偏头痛治疗达成欧洲共识。
相似文献
1
A review of current European treatment guidelines for migraine.偏头痛的欧洲治疗指南述评。
J Headache Pain. 2010 Feb;11(1):13-9. doi: 10.1007/s10194-009-0179-2. Epub 2009 Dec 18.
2
Diagnosis and management of migraine in ten steps.偏头痛的诊断与管理十步骤。
Nat Rev Neurol. 2021 Aug;17(8):501-514. doi: 10.1038/s41582-021-00509-5. Epub 2021 Jun 18.
3
Current clinical practice in disabling and chronic migraine in the primary care setting: results from the European My-LIFE anamnesis survey.基层医疗环境中致残性和慢性偏头痛的当前临床实践：欧洲My-LIFE病史调查结果
BMC Neurol. 2021 Jan 4;21(1):1. doi: 10.1186/s12883-020-02014-6.
4
Principles of migraine diagnosis and management. A synthesis.偏头痛的诊断与管理原则。综述。
Postgrad Med. 2005 May;117(5 Suppl):26-8. doi: 10.3810/pgm.05.2005.suppl41.212.
5
The changing face of migraine.偏头痛的变化面貌。
Curr Pain Headache Rep. 2004 Apr;8(2):85-90. doi: 10.1007/s11916-004-0021-0.
6
Revised French guidelines for the diagnosis and management of migraine in adults and children.法国成人及儿童偏头痛诊断与管理指南修订版。
J Headache Pain. 2014 Jan 8;15(1):2. doi: 10.1186/1129-2377-15-2.
7
Providing Care for Patients with Chronic Migraine: Diagnosis, Treatment, and Management.为慢性偏头痛患者提供护理：诊断、治疗与管理
Pain Pract. 2015 Sep;15(7):688-92. doi: 10.1111/papr.12243. Epub 2014 Oct 1.
8
[Migraine management: current trends and future prospects].[偏头痛的管理：当前趋势与未来前景]
Rev Med Liege. 2008 May-Jun;63(5-6):315-29.
9
1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.第一届欧洲头痛联合会会后会议：回顾 2020 年欧洲头痛联合会大会上呈现的最新进展。
Rev Neurol. 2021 Jun 30;72(s02):S1-S19. doi: 10.33588/rn.72s02.2021155.
10
Survey to evaluate diagnosis and management of headache in primary care: Headache Management Pattern programme.评估基层医疗中头痛诊断与管理的调查：头痛管理模式项目
Curr Med Res Opin. 2008 Dec;24(12):3413-22. doi: 10.1185/03007990802547139.
引用本文的文献
1
Association Between Magnesium Intake and Migraine Among Pre and Postmenopausal Women: A Cross-Sectional Study.绝经前后女性镁摄入量与偏头痛之间的关联：一项横断面研究。
Int J Womens Health. 2025 Aug 29;17:2747-2758. doi: 10.2147/IJWH.S536420. eCollection 2025.
2
Increased risks of retinal vascular occlusion in patients with migraine and the protective effects of migraine treatment: a population-based retrospective cohort study.偏头痛患者视网膜血管闭塞风险增加及偏头痛治疗的保护作用：基于人群的回顾性队列研究。
Sci Rep. 2024 Jul 4;14(1):15429. doi: 10.1038/s41598-024-66363-9.
3
Evidence-Based Opinions from Multidisciplinary Experts on Use of Naturopathic Herbal Remedies in Pain Management.多学科专家关于在疼痛管理中使用自然疗法草药的循证观点。
J Pain Res. 2024 Feb 8;17:599-608. doi: 10.2147/JPR.S432090. eCollection 2024.
4
Efficacy and Safety of Anti-CGRP Monoclonal Antibodies in Prevention of Chronic Migraine: A Bayesian Network Meta-analysis.抗降钙素基因相关肽单克隆抗体预防慢性偏头痛的疗效与安全性：一项贝叶斯网络荟萃分析
Clin Psychopharmacol Neurosci. 2024 Feb 29;22(1):23-32. doi: 10.9758/cpn.23.1109. Epub 2023 Nov 8.
5
Non-Pharmacological Treatment of Primary Headaches-A Focused Review.原发性头痛的非药物治疗——聚焦综述
Brain Sci. 2023 Oct 8;13(10):1432. doi: 10.3390/brainsci13101432.
6
Targeting Peripheral N-Methyl-D-Aspartate Receptor (NMDAR): A Novel Strategy for the Treatment of Migraine.靶向外周N-甲基-D-天冬氨酸受体（NMDAR）：一种治疗偏头痛的新策略。
J Clin Med. 2023 Mar 10;12(6):2156. doi: 10.3390/jcm12062156.
7
Real-World Treatment Patterns and Outcomes Among Patients with Episodic Migraine in China: Results from the Adelphi Migraine Disease Specific Programme™.中国发作性偏头痛患者的真实世界治疗模式与结局：来自阿德尔菲偏头痛特定疾病项目™的结果
J Pain Res. 2023 Feb 3;16:357-371. doi: 10.2147/JPR.S371887. eCollection 2023.
8
Differential Diagnosis of Visual Phenomena Associated with Migraine: Spotlight on Aura and Visual Snow Syndrome.偏头痛相关视觉现象的鉴别诊断：聚焦于先兆和视觉雪综合征。
Diagnostics (Basel). 2023 Jan 9;13(2):252. doi: 10.3390/diagnostics13020252.
9
Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data.肉毒毒素 A（保妥适®）预防治疗慢性偏头痛的有效性：基于 10 年真实世界数据的荟萃分析。
Cephalalgia. 2022 Dec;42(14):1543-1564. doi: 10.1177/03331024221123058. Epub 2022 Sep 8.
10
Magnesium as an Important Factor in the Pathogenesis and Treatment of Migraine-From Theory to Practice.镁作为偏头痛发病机制和治疗的重要因素：从理论到实践。
Nutrients. 2022 Mar 5;14(5):1089. doi: 10.3390/nu14051089.
本文引用的文献
1
EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force.欧洲神经病学学会偏头痛药物治疗指南——欧洲神经病学学会特别工作组修订报告
Eur J Neurol. 2009 Sep;16(9):968-81. doi: 10.1111/j.1468-1331.2009.02748.x.
2
The acute treatment of episodic and chronic migraine in the USA.美国发作性和慢性偏头痛的急性治疗
Cephalalgia. 2009 Aug;29(8):891-7. doi: 10.1111/j.1468-2982.2008.01819.x. Epub 2009 Feb 13.
3
[Evidence based guidelines for the treatment of primary headaches].[原发性头痛治疗的循证指南]
Acta Med Croatica. 2008 May;62(2):99-136.
4
Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan.急性偏头痛的早期干预与非早期干预——“轻度时行动（AwM）”。阿莫曲坦的双盲、安慰剂对照试验。
Cephalalgia. 2008 Apr;28(4):383-91. doi: 10.1111/j.1468-2982.2008.01546.x. Epub 2008 Feb 20.
5
European principles of management of common headache disorders in primary care.欧洲初级保健中常见头痛疾病的管理原则。
J Headache Pain. 2007 Oct;8 Suppl 1:S3-47. doi: 10.1007/s10194-007-0366-y.
6
Patterns of triptans use: a study based on the records of a community pharmaceutical department.曲坦类药物的使用模式：一项基于社区药房记录的研究
Cephalalgia. 2007 Sep;27(9):1000-4. doi: 10.1111/j.1468-2982.2007.01401.x. Epub 2007 Aug 6.
7
[Recommendations guide for the treatment of migraine in the clinical practice].
Rev Clin Esp. 2007 Apr;207(4):190-3. doi: 10.1157/13101849.
8
Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms.1000毫克泡腾阿司匹林的疗效与安全性：偏头痛及偏头痛伴随症状三项试验的个体患者数据荟萃分析
J Neurol. 2007 Jun;254(6):705-12. doi: 10.1007/s00415-007-0547-2. Epub 2007 Apr 10.
9
EFNS guideline on the drug treatment of migraine - report of an EFNS task force.欧洲神经科学联合会偏头痛药物治疗指南——欧洲神经科学联合会特别工作组报告
Eur J Neurol. 2006 Jun;13(6):560-72. doi: 10.1111/j.1468-1331.2006.01411.x.
10
French guidelines for the diagnosis and management of migraine in adults and children.法国成人及儿童偏头痛诊断与管理指南。
Clin Ther. 2004 Aug;26(8):1305-18. doi: 10.1016/s0149-2918(04)80161-9.
Zotero 插件